Aegis Wealth Management (Maryland)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-394
Closed -$228K 124
2025
Q4
$228K Sell
394
-19
-5% -$10.7K 0.13% 114
2025
Q3
$200K Sell
413
-81
-16% -$37.7K 0.11% 122
2025
Q2
$246K Hold
494
0.15% 103
2025
Q1
$246K Buy
+494
New +$268K 0.14% 108

Other funds holding TMO

Aegis Wealth Management (Maryland)'s TMO Position: Q1 2026 in Review

Aegis Wealth Management (Maryland) sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 394 shares — an estimated $228K sold.

Aegis Wealth Management (Maryland) first reported a position in TMO in Q1 2025 and held it in 4 quarters. The position peaked at $246K in Q2 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aegis Wealth Management (Maryland) reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Aegis Wealth Management (Maryland) sold 394 Thermo Fisher Scientific shares in Q1 2026, an estimated $228K.
  • Aegis Wealth Management (Maryland) first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 4 quarters.
  • Aegis Wealth Management (Maryland)'s Thermo Fisher Scientific position peaked at $246K in Q2 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q1 2026, filed 23 Apr 2026.